Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload

Ophthalmology

Volumn 112, Issue 6, 2005, Pages 1062-1065

  Dunaief, Joshua L ^a,c,h   Richa, Chimene ^a   Franks, Edward P ^b   Schultze, Robert L ^b   Aleman, Tomas S ^c   Schenck, John F ^d   Zimmerman, Earl A ^e   Brooks, David G ^f,g  

^a FM Kirby Center for Molecular Ophthalmology   (United States)

^b Scheie Eye Institute ^*

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GE GLOBAL RESEARCH   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

^h 305 Stellar Chance Labs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC FERROCYANIDE; VISUAL PIGMENT; CERULOPLASMIN; IRON;

ACERULOPLASMINEMIA; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BIOPSY; BRAIN; CASE REPORT; CONJUNCTIVAL BIOPSY; DISEASE COURSE; ELECTRORETINOGRAPHY; EPITHELIUM; EPITHELIUM CELL; FLUORESCENCE ANGIOGRAPHY; HOMEOSTASIS; HUMAN; IRON OVERLOAD; MALE; PANCREAS; PATHOGENESIS; PHOTOGRAPHY; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; STAINING; CONJUNCTIVA; GENETICS; IRON DEFICIENCY ANEMIA; METABOLISM; MIDDLE AGED; RETINA DISEASE; RETINA MACULA DEGENERATION;

ANEMIA, IRON-DEFICIENCY; CERULOPLASMIN; CONJUNCTIVA; ELECTRORETINOGRAPHY; EPITHELIUM; FLUORESCEIN ANGIOGRAPHY; HUMANS; IRON; IRON OVERLOAD; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL DISEASES;

EID: 20144377892     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.12.029     Document Type: Article

References (13)

1. Z.L. Harris, Y. Takahashi, H. Miyajima Aceruloplasminemia molecular characterization of this disorder of iron metabolism Proc Natl Acad Sci U S A 92 1995 2539 2543
2. Z.L. Harris, A.P. Durley, T.K. Man, J.D. Gitlin Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux Proc Natl Acad Sci U S A 96 1999 10812 10817
3. S.Y. Jeong, S. David Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system J Biol Chem 278 2003 27144 27148
4. J. Sarkar, V. Seshadri, N.A. Tripoulas Role of ceruloplasmin in macrophage iron efflux during hypoxia J Biol Chem 278 2003 44018 44024
5. K. Yamaguchi, S. Takahashi, T. Kawanami Retinal degeneration in hereditary ceruloplasmin deficiency Ophthalmologica 212 1998 11 14
6. P. Aisen, J.B. Schorr, A.G. Morell A rapid screening test for deficiency of plasma ceruloplasmin and its value in the diagnosis of Wilson's disease Am J Med 28 1960 550 554
7. J.D. Gitlin, J.J. Schroeder, L.M. Lee-Ambrose, R.J. Cousins Mechanisms of caeruloplasmin biosynthesis in normal and copper-deficient rats Biochem J 282 1992 835 839
8. A. Tawara Transformation and cytotoxicity of iron in siderosis bulbi Invest Ophthalmol Vis Sci 27 1986 226 236
9. H. Morita, S. Ikeda, K. Yamamoto Hereditary ceruloplasmin deficiency with hemosiderosis a clinicopathological study of a Japanese family Ann Neurol 37 1995 646 656
10. P. Hahn, Y. Qian, T. Dentchev Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration Proc Natl Acad Sci U S A 101 2004 13850 13855
11. P. Hahn, A.H. Milam, J.L. Dunaief Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane Arch Ophthalmol 121 2003 1099 1105
12. R. Haimovici, D.J. D'Amico, E.S. Gragoudas, S. Sokol Deferoxamine Retinopathy Study Group The expanded clinical spectrum of deferoxamine retinopathy Ophthalmology 109 2002 164 171
13. H. Miyajima, Y. Takahashi, T. Kamata Use of desferrioxamine in the treatment of aceruloplasminemia Ann Neurol 41 1997 404 407